Regulatory T cells in systemic lupus erythematosus: past, present and future.
about
Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acidCommensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2.Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.HDAC inhibition in lupus models.The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosusThe pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cellsAberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activityHDAC expression and activity is upregulated in diseased lupus-prone mice.Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of ProlactinRegulatory T cell subsets in filarial infection and their function.The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: A Novel Hypothesis.Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.Phenotypical and functional specialization of FOXP3+ regulatory T cells.Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus.Inflammation and adaptive immunity in Parkinson's disease.Skin-derived TSLP systemically expands regulatory T cells.Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.Translating epigenetics into clinic: focus on lupus.Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion.Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections.
P2860
Q33778359-7492E23E-BDAC-42BD-8779-68D6CD07AF09Q33971938-4333669E-DF58-4805-9707-B80BA8829914Q34106220-095B5B1D-62D1-4A22-9793-3752E686714FQ34233668-7F8D4D7D-FBFC-4A10-82B7-E3733DA99367Q35016981-0A064574-9BE6-403D-85D8-B8F95A013A60Q35074594-6F857685-A240-4321-B333-A79200371866Q35201052-6A280455-3038-4D4A-B4C8-4DBED116762DQ35344378-0BC6EA43-A1EF-4356-A0A8-A48763637C91Q35345025-0AA68B38-5899-4F10-8D12-35BA45922744Q35557975-2482B35A-4BEC-40A3-8D0E-8C51A1BFBE52Q35931795-CF7EEE03-8875-4785-B49E-40E5C92CDE5FQ36246034-4DECC077-ACE1-4B2A-A513-81ED09C20A15Q36338516-A8B16861-B128-4526-B1C0-9DFB17A6B73DQ36566751-2B503D0E-8B76-497D-89EF-97581756E9CBQ37205678-1EF7E59C-5869-4BAD-A5BF-0A323C9F9B85Q37250644-5C80A399-9DBC-43C5-A27D-944026ED0322Q37361089-77AE4863-FC23-479B-9019-4E81386332EEQ37454041-B6FEAF6B-C784-4540-A751-80CAB323C4A5Q37475806-81EE365E-5A91-409E-A817-A55A8712E026Q37776658-3010D8E3-DFDB-4533-954E-0EB5C2948B39Q37832385-E8DDB147-D6FD-4878-99AC-977188FD83BCQ37864851-5C578905-564A-424D-B664-E603D94282DAQ37982378-260071C4-ABB4-4F86-98D5-BB4C6EF37DDFQ38996948-DCC909F6-08AD-40C1-B94C-61EDE1892138Q40963026-F728529D-B485-4FCE-8064-2086F705F0E6Q41228881-065DA2A5-C66E-47AC-99E8-A3DD5BA0175BQ41880094-06283239-26BB-4E01-8B58-C669E40D27BFQ42718178-FA08E20F-2B9F-4019-A6AB-C75B69C93FB0Q44672907-446D2891-EE29-4117-9BB8-CA6516B43363Q54196263-61FF9EC6-0CB3-40E4-A0F4-1C0646FE98D3
P2860
Regulatory T cells in systemic lupus erythematosus: past, present and future.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@en
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@nl
type
label
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@en
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@nl
prefLabel
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@en
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@nl
P2860
P921
P356
P1476
Regulatory T cells in systemic lupus erythematosus: past, present and future.
@en
P2093
David A Horwitz
P2860
P2888
P356
10.1186/AR2511
P577
2008-11-14T00:00:00Z
P5875
P6179
1002850642